The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person22

Viatris Inc

Company

5 records in the corpus

VIASAT INC

Company

13 records in the corpus

Lyntris Inc.

Company

13 records in the corpus

Visa Inc

Company

14 records in the corpus

VIVOS INC

Company

6 records in the corpus

CURIS INC

Company

5 records in the corpus

VirTra, Inc

Company

1 records in the corpus

Polaris Inc.

Company

7 records in the corpus

Vivakor, Inc.

Company

8 records in the corpus

V2X, Inc.

Company

7 records in the corpus

Arteris, Inc.

Company

21 records in the corpus

ENTEGRIS INC

Company

8 records in the corpus

Onterris, Inc.

Company

3 records in the corpus

DarkIris Inc.

Company

6 records in the corpus

NUSATRIP Inc

Company

1 records in the corpus

AtriCure, Inc.

Company

10 records in the corpus

VIP Play, Inc.

Company

3 records in the corpus

VERU INC.

Company

3 records in the corpus

VEEA INC.

Company

7 records in the corpus

C3is Inc.

Company

8 records in the corpus

Pulmatrix, Inc.

Company

2 records in the corpus

OZ VISION INC.

Company

1 records in the corpus

Primary record8

Viatris Inc filed SCHEDULE 13G/A

0001036325-26-000035.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001036325-25-000006 0001036325 XXXXXXXX LIVE 9 Common Stock 09/30/2026 0001792044 Viatris Inc 92556V106 1000 MYLAN BOULEVARD 1000

06 Nov 2026 · sec daily index

Viatris Inc filed 8-K

Item 2.02 Results of Operations and Financial Condition. On November 5, 2026 , Viatris Inc. (“Viatris” or the “Company”) issued a press release reporting the Company's financial results for the period ended September 30,

05 Nov 2026 · sec daily index

Pacira BioSciences, Inc. filed 8-K

Item 7.01. Regulation FD Disclosure. As previously disclosed, on October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the “Company” or “Pacira”), entered into the Agreement and Plan of Merger (the “Merger A

05 Nov 2026 · sec daily index

Xeris Biopharma Holdings, Inc. filed 8-K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Director Menassie Taddese Effective as of Novemb

02 Nov 2026 · sec daily index

Pacira BioSciences, Inc. filed 8-K

Item 1.01 Entry into a Material Definitive Agreement. On October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the Company or Pacira ), entered into an Agreement and Plan of Merger (the Merger Agreement ) wi

08 Oct 2026 · sec daily index

Viatris Inc filed 8-K

Item 1.01 Entry into a Material Definitive Agreement. Agreement and Plan of Merger On October 8, 2026, Viatris Inc., a Delaware corporation ( Viatris ), entered into an Agreement and Plan of Merger (the Merger Agreement

08 Oct 2026 · sec daily index

HARROW, INC. filed 8-K

Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on August 3, 2026, Harrow, Inc. (the "Company") entered into an Asset Purchase Agreement (the "Original Purchase Agreement") with Viatris In

05 Oct 2026 · sec daily index

FMR LLC filed SCHEDULE 13G/A

0000315066-26-002299.txt : 20260908 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000315066-26-002166 0000315066 XXXXXXXX LIVE 1 COMMON STOCK 08/31/2026 0001792044 VIATRIS INC 92556V106 1000 MYLAN BOULEVARD CANO

08 Sep 2026 · sec daily index